EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway

Danielle M Galvin iD, Sara Fernandez-Garcia, Emma Dawson, Ciara Pryce, Billy P Egan iD, Niamh C Clarke iD, Alison L Reynolds iD, Derek A Costello iD

International Journal of Molecular Sciences · 23.05.2025 · 26 (11) · 5050

DOI: 10.3390/ijms26115050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.05.2025. Verfasst von Danielle M Galvin und 7 weiteren Autor:innen. Beteiligte Einrichtung: UCD School of Biomolecular & Biomedical Science, University College Dublin, D04 V1W8 Dublin, Ireland. Hauptthemen laut MEDLINE: Microglia, Sesquiterpenes, Inflammation, Lactones. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Marie Skłodowska-Curie Actions research and innovation programme, UCD STEM Challenge Fund, Graduate Research Scholarship from UCD SBBS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are characterised by the progressive loss of neurons, leading to a decline in specific brain functions. Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most prevalent, affecting approximately 60 million people worldwide. The pathogenesis of these diseases is complex, combining inflammatory, oxidative, and excitotoxic processes that result in neuronal dysfunction and death. Despite recent advances, there is currently no cure for AD and PD. Available therapies demonstrate limited efficacy, highlighting the continuing need for novel therapeutic approaches. Ergolide, a naturally occurring sesquiterpene lactone from the Inula brittanica plant, has shown immunoregulatory properties in systemic immune cells and potential applications in certain cancers. This study examines whether the therapeutic effects of ergolide extend to the brain. We explored its mechanisms of action in vitro, and its capacity to restore behavioural integrity in zebrafish models of inflammation and neurotoxicity in vivo. We report the ability of ergolide to attenuate inflammatory cytokine and nitric oxide (NO) production from microglia in response to toll-like receptor activation. We further propose a role for the NFκB and cysteinyl leukotriene (CysLT) pathways in ergolide-mediated regulation of microglial activation. Ergolide did not protect against oxidative-induced neuronal death in vitro or mitigate seizure activity in zebrafish. Instead, we revealed a pro-oxidant and cytotoxic effect on neuroblastoma cells. Importantly, ergolide improved survival and alleviated the dysfunction in sensorimotor behaviour in a zebrafish model of inflammation. Our findings reveal a neuroprotective effect of ergolide, likely stemming from its immunoregulatory capacity. We also support further investigation of the CysLT pathway as a therapeutic target for neuroinflammatory-related disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaSesquiterpenesInflammationLactonesCysteineLeukotrienesAnimalsZebrafishSignal TransductionHumansNitric OxideDisease Models, AnimalCytokinesNF-kappa B

Stichwörter der Autor:innen

NFκBTLRcytokinesmicroglianitric oxidezebrafish larvae

Substanzen

SesquiterpenesLactonesCysteineNitric OxideLeukotrienesCytokinesNF-kappa B

Autor:innen und Institutionen

  • UCD School of Biomolecular & Biomedical Science, University College Dublin, D04 V1W8 Dublin, Ireland.
  • UCD Conway Institute, University College Dublin, D04 V1W8 Dublin, Ireland.
  • UCD School of Veterinary Medicine, University College Dublin, D04 W6F6 Dublin, Ireland.

ORCID-Profile: Danielle M Galvin, Billy P Egan, Niamh C Clarke, Alison L Reynolds, Derek A Costello

Förderung

  • Horizon 2020 Marie Skłodowska-Curie Actions research and innovation programme
  • UCD STEM Challenge Fund
  • Graduate Research Scholarship from UCD SBBS
  • European Union’s Horizon 2020 Marie Skłodowska-Curie Actions research and innovation programme

Zitieren

APA

Galvin, D. M., Fernandez-Garcia, S., Dawson, E., Pryce, C., Egan, B. P., Clarke, N. C., Reynolds, A. L., & Costello, D. A. (2025). Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway. International Journal of Molecular Sciences, 26(11), 5050. https://doi.org/10.3390/ijms26115050

Vancouver

Galvin DM, Fernandez-Garcia S, Dawson E, Pryce C, Egan BP, Clarke NC, et al. Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway. International Journal of Molecular Sciences. 2025;26(11):5050. doi:10.3390/ijms26115050

BibTeX
@article{Galvin2025,
  author = {Galvin, Danielle M and Fernandez-Garcia, Sara and Dawson, Emma and Pryce, Ciara and Egan, Billy P and Clarke, Niamh C and Reynolds, Alison L and Costello, Derek A},
  title = {Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {11},
  pages = {5050},
  doi = {10.3390/ijms26115050}
}
Kostenlos starten →